Sign In
Buy CMPGY
$32.19
-0.440 (-1.35%)
At Close: Jun 23, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass, Inc. - COMP
04:32pm, Tuesday, 23'rd Jun 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP). Such investors are advise
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass, Inc. - COMP
10:00am, Thursday, 18'th Jun 2026
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. ("Compass" or the "Company") (NYSE: COMP). Such investors are advised to contact
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Compass, Inc. – COMP
05:34pm, Tuesday, 16'th Jun 2026
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP). Such investors are advised
AI/R Compass UOL Achieves the AWS Business Value Realization Competency
03:00pm, Tuesday, 16'th Jun 2026
SAN FRANCISCO, June 16, 2026 (GLOBE NEWSWIRE) -- AI/R Compass UOL, a subsidiary of AI/R—a technology company specialized in agentic AI—, announced today that it has achieved the AWS Business Value
COMP Investors Have Opportunity to Join Compass, Inc. Fraud Investigation with the Schall Law Firm
05:00pm, Friday, 12'th Jun 2026
LOS ANGELES--(BUSINESS WIRE)---- $COMP--COMP Investors Have Opportunity to Join Compass, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass, Inc. - COMP
07:05pm, Thursday, 11'th Jun 2026
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. ("Compass" or the "Company") (NYSE: COMP). Such investors are advised to contact D
Compass Diversified Announces CEO Succession Plan
06:30am, Thursday, 11'th Jun 2026
Co-Founder and Chief Executive Officer Elias Sabo to Retire at Year End Zach Sawtelle Appointed Chief Operating Officer and Named CEO Successor Company Reaffirms Full-Year 2026 Outlook; Review of Mana
Compass Group: Why This Compounder Giant May Not Outperform The Market In 2026
11:45am, Wednesday, 10'th Jun 2026
Compass Group (CMPGY) remains a high-quality compounder, but current valuation leaves limited upside, justifying a 'Hold' rating. CMPGY delivered 9% H1 FY 2026 revenue growth and 12% EBIT growth, outp
Compass, Inc. Investigated by the Portnoy Law Firm
11:07am, Wednesday, 10'th Jun 2026
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass , Inc. , (“ Compass " or the "Company") ( NYSE : COMP ) investors that the firm has initiated an investigation int
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass, Inc. - COMP
04:54pm, Tuesday, 09'th Jun 2026
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP). Such investors are advised
Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win
09:07am, Monday, 08'th Jun 2026
Compass Therapeutics NASDAQ: CMPX Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody,
Machine Learning and AI Expert Dennis Zhang Affiliates With Compass Lexecon
07:30am, Monday, 08'th Jun 2026
WASHINGTON, June 08, 2026 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced that Dennis Zhang, a Professor of Operations and Marketing at Washingt
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:30am, Friday, 05'th Jun 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
AG's antitrust probe decimates Compass stock price by nearly 13%
01:45pm, Thursday, 04'th Jun 2026
Compass' stock price plummeted Wednesday after news broke that the New York Attorney General's office was investigating the brokerage over antitrust concerns.
Real-Estate Giant Compass Under Antitrust Investigation in New York
04:31pm, Wednesday, 03'rd Jun 2026
The state attorney general is investigating Compass after it closed a $1.6 billion acquisition of a rival brokerage firm. Compass shares fell 12% Wednesday.
